(Q81753029)
Statements
Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer (English)
John Nemunaitis
Irene Eiseman
Casey Cunningham
Neil Senzer
Adrienne Williams
Peter F Lenehan
Stephen C Olson
Paul Bycott
Michael Schlicht
Rebecca Zentgraff
Dong M Shin